Can a patient with diabetes mellitus (DM) type 2 die from complications related to their condition?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Type 2 Diabetes Be Fatal?

Yes, patients with type 2 diabetes can die from complications related to their condition, with approximately two-thirds dying from cardiovascular disease and mortality risk being 1.8–2.6 times higher than in people without diabetes. 1

Acute Life-Threatening Complications

Type 2 diabetes can cause immediate, potentially fatal metabolic crises:

  • Hyperosmolar hyperglycemic state (HHS) carries a 15% mortality rate even with proper management, substantially higher than the 5% mortality rate of diabetic ketoacidosis 1
  • Both HHS and diabetic ketoacidosis can occur in type 2 diabetes, with prognosis worsening at extremes of age and in the presence of coma and hypotension 1
  • These acute complications result from severe insulin deficiency combined with elevated counterregulatory hormones, leading to extreme hyperglycemia, osmotic diuresis, and electrolyte depletion 1

Chronic Cardiovascular Mortality

Cardiovascular disease represents the primary cause of death in type 2 diabetes:

  • Up to 80% of type 2 diabetes patients will develop or die of macrovascular disease, making cardiovascular complications the dominant mortality driver 1
  • The cardiovascular death rate is 4.4-fold increased even in diabetic patients without classical risk factors (hypertension, hypercholesterolemia, or smoking) 2
  • Patients experience decreased survival after myocardial infarction, increased congestive heart failure, and higher occurrence of silent ischemia 2

Risk Stratification by Control Status

The mortality risk varies dramatically based on risk factor control:

  • Patients with all five risk factors controlled (HbA1c, LDL cholesterol, blood pressure, albuminuria, smoking) have near-normal mortality with a hazard ratio of only 1.06 compared to non-diabetic controls 3
  • Each additional uncontrolled risk factor increases mortality in a stepwise fashion 3
  • Poor glycemic control (HbA1c >6.0%) significantly predicts coronary heart disease morbidity and mortality 2

Microvascular Complications Contributing to Mortality

While less immediately fatal, microvascular complications substantially increase mortality risk:

  • Nephropathy is now the leading cause of end-stage renal disease, which carries high mortality 1
  • Diabetic foot complications represent a "super-complication" combining neuropathy, microangiopathy, and macroangiopathy that can lead to sepsis and death 4
  • Retinopathy, neuropathy, and lower extremity amputation all contribute to reduced life expectancy 1

Predictors of Cardiovascular Death

Specific factors that predict cardiovascular mortality in type 2 diabetes include:

  • Older age, male sex, longer diabetes duration, and lower BMI 1
  • Hypertension, macrovascular disease, retinopathy, nephropathy, and neuropathy 1
  • Treatment with insulin (with or without oral medication), higher LDL cholesterol 1
  • History of transient ischemic attack, stroke, angina, myocardial infarction, coronary artery disease, and peripheral vascular disease 1

Life Expectancy Impact

The overall mortality burden is substantial:

  • Life expectancy remains substantially shorter for patients with type 2 diabetes compared to equivalent individuals without diabetes 5
  • When obesity is present (particularly BMI ≥35 kg/m²), life expectancy can be reduced by 5–20 years 1
  • Obesity hypoventilation syndrome, when present with BMI >50 kg/m², carries mortality as high as 24% at 1.5–2 years after diagnosis 1

Critical Pitfall to Avoid

The most important clinical error is failing to recognize that diabetes is a major cause of morbidity and death requiring aggressive multifactorial risk factor management, not just glycemic control 1. Cardiovascular risk reduction through blood pressure control, lipid management, smoking cessation, and antiplatelet therapy is equally or more important than glucose control alone for preventing mortality 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiovascular mortality and morbidity in type-2 diabetes mellitus.

Diabetes research and clinical practice, 1996

Research

[Type 2 diabetes complications].

Presse medicale (Paris, France : 1983), 2013

Research

Overall mortality in diabetes mellitus: where do we stand today?

Diabetes technology & therapeutics, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.